Mixed options sentiment in Pfizer (PFE), with shares up 2c, or 0.1%, near $25.16. Options volume relatively light with 28k contracts traded and calls leading puts for a put/call ratio of 0.24, compared to a typical level near 0.52. Implied volatility (IV30) dropped 1.1 near 18.37,in the lowest 10% of observations over the past year, suggesting an expected daily move of $0.29. Put-call skew flattened, suggesting a modestly bullish tone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- This Activist Investor Ramped Up Salesforce (NYSE:CRM) Stake by 50% in Q2
- Pfizer’s (PFE) Sickle Cell Drug Fails to Meet Its Main Goal
- Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
- Pfizer’s Promising Study on PF-07248144: A Potential Game-Changer in Cancer Treatment
- Pfizer’s Latest Study on HER2-positive Breast Cancer: Key Insights for Investors